Organization Overview
Alternative names
acetaminophen (tylenol) (4 trials)
alteplase (Activase) (4 trials)
alvimopan (entereg) (2 trials)
betamethasone (celestone) (1 trial)
cyproheptadine (periactin) (2 trials)
dexmedetomidine (precedex) (1 trial)
florbetapir (Amyvid) (1 trial)
glyburide (micronase) (1 trial)
glycopyrronium (robinul) (1 trial)
allogeneic bone marrow (3 trials)
allogeneic cord blood (2 trials)
allogeneic stem cells (1 trial)
allogenic t cell-depleted hematopoietic stem cells (1 trial)
autologous hematopoietic stem cells (2 trials)
autologous mononuclear stem cell (3 trials)
autologous umbilical cord blood (2 trials)
bicalutamide (casodex) (2 trials)
bone marrow derived mononuclear cells (1 trial)
chlorhexidine (hibitane) (2 trials)
cisplatin (platinol) (6 trials)
cyclophosphamide (cytoxan) (17 trials)
cyclosporine (sandimmune) (2 trials)
daratumumab (darzalex) (1 trial)
docetaxel (taxotere) (4 trials)
enoxaparin (lovenox) (2 trials)
fenoldopam (corlopam) (1 trial)
fluconazole (diflucan) (2 trials)
fludarabine (fludara) (11 trials)
fluorouracil (efudex) (6 trials)
fluticasone (cutivate) (1 trial)
hyaluronidase (human recombinant) (Hylenex) (1 trial)
lenalidomide (revlimid) (4 trials)
leuprolide (lupron) (2 trials)
magnesium sulfate (Tis-U-Sol) (1 trial)
melphalan (alkeran) (8 trials)
methadone (methadose) (1 trial)
montelukast (singulair) (3 trials)
mycophenolate (CellCept) (6 trials)
prednisone (meticorten) (6 trials)
quetiapine (seroquel) (1 trial)
rituximab (rituxan) (4 trials)
sargramostim (leukine) (9 trials)
sirolimus (rapamune) (8 trials)
tacrolimus (prograf) (10 trials)
triptorelin (Trelstar) (2 trials)
vasopressin (vasostrict) (1 trial)
vedolizumab (entyvio) (1 trial)
abemaciclib (verzenio) (2 trials)
adenovirus-specific t-cells (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (4 trials)
allogeneic natural killer cells (1 trial)
anastrozole (arimidex) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (3 trials)
asciminib (Scemblix) (1 trial)
atezolizumab (Tecentriq) (3 trials)
atorvastatin (lipitor) (1 trial)
autologous cd34+ cells (1 trial)
autologous humanized anti-cd19 and anti-cd20 dual specific car-t cells (2 trials)
azacitidine (vidaza) (3 trials)
azathioprine (imuran) (1 trial)
belantamab mafodotin (TECVAYLI) (1 trial)
bendamustine (treanda) (1 trial)
bevacizumab (avastin) (1 trial)
bk cytotoxic t lymphocytes (1 trial)
blinatumomab (blincyto) (2 trials)
bone marrow derived mesenchymal stem cells (2 trials)
cabozantinib (cometriq) (1 trial)
capecitabine (xeloda) (2 trials)
carboplatin (paraplatin) (2 trials)
celecoxib (celebrex) (1 trial)
cemiplimab (libtayo) (1 trial)
cladribine (leustatin) (2 trials)
clofarabine (clolar) (1 trial)
cmv-specific t-cells (1 trial)
cord blood hematopoietic stem cell (1 trial)
COVID-19 convalescent plasma (1 trial)
dactinomycin (cosmegen) (1 trial)
decitabine (dacogen) (2 trials)
doxorubicin (Doxil) (4 trials)
doxycycline (vibramycin) (2 trials)
elotuzumab (empliciti) (1 trial)
etoposide (vepesid) (5 trials)
exemestane (aromasin) (1 trial)
Filgrastim (neupogen) (4 trials)
fulvestrant (faslodex) (2 trials)
gemcitabine (gemzar) (6 trials)
haploidentical mononuclear cells (1 trial)
incobotulinumtoxinA (Xeomin) (1 trial)
irinotecan (Camptosar) (2 trials)
Isatuximab (Sarclisa) (2 trials)
levetiracetam (keppra) (1 trial)
mitoxantrone (novantrone) (3 trials)
oxaliplatin (eloxatin) (3 trials)
pegaspargase (oncaspar) (1 trial)
pembrolizumab (keytruda) (2 trials)
plerixafor (mozobil) (1 trial)
pomalidomide (pomalyst) (2 trials)
porfimer (photofrin) (2 trials)
propranolol (inderal) (1 trial)
recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)
regadenoson (lexiscan) (3 trials)
ruxolitinib (jakafi) (1 trial)
saquinavir (invirase) (1 trial)
tamoxifen (nolvadex) (1 trial)
temozolomide (temodar) (1 trial)
temsirolimus (torisel) (1 trial)
ticagrelor (brilinta) (1 trial)
tildrakizumab (Ilumetri) (1 trial)
tocilizumab (actemra) (4 trials)
vandetanib (caprelsa) (1 trial)
venetoclax (venclexta) (3 trials)
acetazolamide (diamox) (1 trial)
aminolevulinic acid (levulan) (1 trial)
antithrombin iii (human) (thrombate iii) (1 trial)
autologous cd34+pbsc, transduced with a lentiviral vector (-889itga2b-bddfviii-wpts(mut6)(vsvg) (1 trial)
bupivacaine (Exparel) (1 trial)
deferoxamine (desferal) (1 trial)
duloxetine (Cymbalta) (1 trial)
estradiol (progynon depot) (2 trials)
everolimus (zortress) (1 trial)
hydralazine (apresoline) (1 trial)
labetalol (trandate) (1 trial)
levobupivacaine (chirocaine) (1 trial)
metoprolol (lopressor) (1 trial)
Abdominal Neoplasms (Phase 4)
Abdominal Pain (Phase 1)
Acute Disease (Phase 1)
Acute Kidney Injury (Phase 3)
Acute Pain (Phase 4)
Adenocarcinoma (Phase 2)
Adenoviridae Infections (Phase 2)
Affective Disorders, Psychotic (Phase 4)
Alzheimer Disease (Phase 3)
Amyloidosis (Phase 4)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Anemia, Sickle Cell (Phase 3)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Astrocytoma (Phase 2)
Atherosclerosis (Phase 4)
Bipolar Disorder (Phase 4)
Birth Weight (Phase 3)
Brain Diseases (Phase 1)
Brain Injuries (Phase 3)
Brain Injuries, Traumatic (Phase 3)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 3)
Carcinoma (Phase 4)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinosarcoma (Phase 2)
Central Nervous System Neoplasms (Phase 2)
Cerebral Hemorrhage (Phase 1)
Chondrosarcoma (Phase 2)
Clostridium Infections (Phase 4)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 3)
Colorectal Neoplasms (Phase 2)
Common Variable Immunodeficiency (Phase 2)
Communicable Diseases (Phase 3)
Congenital Abnormalities (Phase 1)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Cushing Syndrome (Phase 2)
Cytomegalovirus Infections (Phase 2)
Delirium (Phase 3)
Diabetes, Gestational (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 2)
Diarrhea (Phase 2)
Disease (Phase 4)
Ductus Arteriosus, Patent (Phase 3)
Dyspepsia (Phase 1)
Emergencies (Phase 4)
Endometrial Neoplasms (Phase 2)
Eosinophilic Esophagitis (Phase 3)
Epilepsy (Phase 4)
Epstein-Barr Virus Infections (Phase 2)
Esophageal Neoplasms (Phase 2)
Esophagitis (Phase 3)
Fatigue (Phase 1)
Fatty Liver (Phase 4)
Feeding and Eating Disorders (Phase 4)
Fibrosarcoma (Phase 2)
Fibrosis (Phase 1)
Fractures, Bone (Phase 4)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Glomerulosclerosis, Focal Segmental (Phase 1)
Graft vs Host Disease (Phase 3)
Granulomatous Disease, Chronic (Phase 2)
Headache (Phase 4)
Head and Neck Neoplasms (Phase 3)
Heart Diseases (Phase 3)
Hemangioma (Phase 2)
Hemangioma, Capillary (Phase 2)
Hematologic Diseases (Phase 4)
Hematologic Neoplasms (Phase 2)
Hemophilia A (Phase 1)
Hemorrhage (Phase 1)
Hepatic Encephalopathy (Phase 1)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 2)
Hydrocephalus (Phase 4)
Hypertension (Phase 3)
Hypertension, Pulmonary (Phase 3)
Immune System Diseases (Phase 3)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Immunologic Deficiency Syndromes (Phase 2)
Infections (Phase 3)
Inflammation (Phase 3)
Irritable Bowel Syndrome (Phase 1)
Laryngopharyngeal Reflux (Phase 3)
Leukemia (Phase 4)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 4)
Leukemia, Myeloid, Acute (Phase 4)
Lipid Metabolism Disorders (Phase 1)
Liver Cirrhosis (Phase 1)
Liver Diseases (Phase 4)
Liver Neoplasms (Phase 1)
Lung Diseases (Phase 2)
Lung Diseases, Interstitial (Phase 2)
Lung Neoplasms (Phase 2)
Lymphangioma (Phase 1)
Lymphatic Abnormalities (Phase 1)
Lymphohistiocytosis, Hemophagocytic (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Mental Disorders (Phase 4)
Metabolic Diseases (Phase 1)
Mixed Tumor, Mullerian (Phase 2)
Mood Disorders (Phase 4)
Mucositis (Phase 3)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Mycoses (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Myocardial Ischemia (Phase 4)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Squamous Cell (Phase 2)
Nervous System Neoplasms (Phase 1)
Neuralgia (Phase 2)
Neuroblastoma (Phase 2)
Neurofibroma (Phase 1)
Neurofibromatoses (Phase 4)
Neurofibromatosis 1 (Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 4)
Oligodendroglioma (Phase 2)
Osteoarthritis (Phase 4)
Osteoporosis (Phase 3)
Osteosarcoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Overweight (Phase 2)
Pain, Postoperative (Phase 4)
Pancreatic Neoplasms (Phase 3)
Peripheral Nervous System Diseases (Phase 2)
Plasmacytoma (Phase 2)
Pneumonia (Phase 3)
Polycystic Ovary Syndrome (Phase 1)
Port-Wine Stain (Phase 2)
Postoperative Hemorrhage (Phase 1)
Preleukemia (Phase 3)
Prostatic Neoplasms (Phase 3)
Psychotic Disorders (Phase 4)
Recurrence (Phase 2)
Renal Insufficiency (Phase 3)
Respiratory Distress Syndrome (Phase 3)
Respiratory Distress Syndrome, Newborn (Phase 3)
Respiratory Insufficiency (Phase 3)
Rhabdomyosarcoma (Phase 2)
Rib Fractures (Phase 4)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Schizophrenia (Phase 4)
Scleroderma, Diffuse (Phase 3)
Scleroderma, Localized (Phase 1)
Scleroderma, Systemic (Phase 3)
Sclerosis (Phase 4)
Scoliosis (Phase 3)
Seizures (Phase 4)
Shock (Phase 2)
Shock, Septic (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Stomatitis (Phase 3)
Stroke (Phase 4)
Substance-Related Disorders (Phase 1)
Surgical Wound Infection (Phase 3)
Syndrome (Phase 2)
Tenosynovitis (Phase 4)
Thalassemia (Phase 2)
Thrombosis (Phase 2)
Tissue Adhesions (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Ulcer (Phase 3)
Upper Extremity Deep Vein Thrombosis (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Virus Diseases (Phase 2)
Weight Loss (Phase 2)
Wound Infection (Phase 3)
Wounds and Injuries (Phase 4)